Knights of Columbus Asset Advisors LLC Sells 1,065 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Knights of Columbus Asset Advisors LLC reduced its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 57.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 783 shares of the medical instruments supplier’s stock after selling 1,065 shares during the period. Knights of Columbus Asset Advisors LLC’s holdings in ICU Medical were worth $78,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Covestor Ltd increased its holdings in shares of ICU Medical by 86.4% during the 1st quarter. Covestor Ltd now owns 123 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 57 shares during the last quarter. Captrust Financial Advisors grew its holdings in ICU Medical by 4.5% during the second quarter. Captrust Financial Advisors now owns 1,327 shares of the medical instruments supplier’s stock valued at $218,000 after purchasing an additional 57 shares during the last quarter. Osaic Holdings Inc. raised its position in shares of ICU Medical by 8.9% in the second quarter. Osaic Holdings Inc. now owns 1,012 shares of the medical instruments supplier’s stock valued at $180,000 after purchasing an additional 83 shares during the period. First Republic Investment Management Inc. lifted its stake in shares of ICU Medical by 7.6% in the first quarter. First Republic Investment Management Inc. now owns 1,438 shares of the medical instruments supplier’s stock worth $237,000 after buying an additional 102 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its holdings in shares of ICU Medical by 4.1% during the 2nd quarter. Wells Fargo & Company MN now owns 2,722 shares of the medical instruments supplier’s stock worth $485,000 after buying an additional 106 shares during the period. Institutional investors and hedge funds own 96.10% of the company’s stock.

Wall Street Analyst Weigh In

Separately, KeyCorp boosted their target price on shares of ICU Medical from $134.00 to $136.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 28th. One investment analyst has rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $123.00.

ICU Medical Price Performance

Shares of ICUI stock opened at $95.77 on Monday. ICU Medical, Inc. has a 12 month low of $78.28 and a 12 month high of $212.43. The company has a current ratio of 2.53, a quick ratio of 1.06 and a debt-to-equity ratio of 0.74. The stock has a 50 day moving average of $102.30 and a 200-day moving average of $98.34.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 EPS for the quarter, beating the consensus estimate of $0.85 by $0.39. The firm had revenue of $587.86 million during the quarter, compared to analysts’ expectations of $564.77 million. ICU Medical had a negative net margin of 1.31% and a positive return on equity of 6.35%. Research analysts predict that ICU Medical, Inc. will post 3.52 EPS for the current year.

Insider Activity at ICU Medical

In other ICU Medical news, VP Daniel Woolson sold 791 shares of the company’s stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $98.27, for a total value of $77,731.57. Following the completion of the transaction, the vice president now owns 13,980 shares of the company’s stock, valued at approximately $1,373,814.60. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, VP Daniel Woolson sold 791 shares of the firm’s stock in a transaction on Friday, March 15th. The stock was sold at an average price of $98.27, for a total value of $77,731.57. Following the completion of the transaction, the vice president now directly owns 13,980 shares of the company’s stock, valued at $1,373,814.60. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director George A. Lopez sold 1,890 shares of the business’s stock in a transaction on Monday, March 11th. The shares were sold at an average price of $104.22, for a total transaction of $196,975.80. Following the completion of the sale, the director now directly owns 317,753 shares in the company, valued at approximately $33,116,217.66. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 24,262 shares of company stock worth $2,545,532. Company insiders own 6.70% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.